Cryptococcal meningoencephalitis associated with the long-term use of ruxolitinib

被引：23
|
作者：
Chen, Chih-Cheng [1 ,2 ]
Chen, Yi-Yang [1 ]
Huang, Cih-En [1 ]
机构：
[1] Chang Gung Mem Hosp, Dept Med, Div Hematol & Oncol, Chiayi, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
来源：
ANNALS OF HEMATOLOGY | 2016年 / 95卷 / 02期
关键词：
Cryptococcus; Meningitis; Myeloproliferative neoplasm; Ruxolitinib; Myelofibrosis; HIV-seronegative; JAK INHIBITION; CELL-FUNCTION; MYELOFIBROSIS;
D O I：
10.1007/s00277-015-2532-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 362
页数：2
相关论文
共 50 条
  • [1] Cryptococcal meningoencephalitis associated with the long-term use of ruxolitinib
    Chih-Cheng Chen
    Yi-Yang Chen
    Cih-En Huang
    Annals of Hematology, 2016, 95 : 361 - 362
  • [2] Cryptococcal meningitis in an immunocompetent patient with primary myelofibrosis on long-term ruxolitinib: report of a rare case and review of literature
    Chakrabarti A.
    Sood N.
    memo - Magazine of European Medical Oncology, 2018, 11 (4) : 348 - 350
  • [3] Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis
    Tefferi, Ayalew
    Begna, Kebede
    Hogan, William J.
    Litzow, Mark R.
    Hanson, Curtis A.
    Pardanani, Animesh
    BLOOD, 2011, 118 (21) : 764 - 764
  • [4] Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD
    Sobash, Philip T.
    Guddati, Achuta K.
    Kota, Vamsi
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
  • [5] Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis
    Tefferi, Ayalew
    Litzow, Mark R.
    Pardanani, Animesh
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1455 - 1457
  • [6] A case report of cryptococcal meningitis associated with ruxolitinib
    Tsukui, Daisuke
    Fujita, Hiroaki
    Suzuki, Keisuke
    Hirata, Koichi
    MEDICINE, 2020, 99 (13) : E19587
  • [7] Cryptococcal meningoencephalitis: use of cryptococcal antigen titres as predictor of clinical response
    Hui, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S121 - S121
  • [8] Clinical Features Associated with Long-Term Ruxolitinib Exposure in Myelofibrosis and Predictive Role of Neutrophils
    Masarova, Lucia
    Bose, Prithviraj
    Pemmaraju, Naveen
    Zhou, Lingsha
    Pierce, Sherry A.
    Estrov, Zeev E.
    Kantarjian, Hagop
    Verstovsek, Srdan
    BLOOD, 2021, 138
  • [9] Neutropenia Associated with Long-Term Ceftaroline Use
    LaVie, Katherine W.
    Anderson, Scott W.
    O'Neal, Hollis R., Jr.
    Rice, Todd W.
    Saavedra, Tatiana C.
    O'Neal, Catherine S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 264 - 269
  • [10] ALOPECIA ASSOCIATED WITH LONG-TERM METYRAPONE USE
    HARRIS, PL
    CLINICAL PHARMACY, 1986, 5 (01): : 66 - 68
12345